Literature DB >> 26511630

Breast MR biopsy: Pathological and radiological correlation.

Chloé Dratwa1, Aurélie Jalaguier-Coudray2, Jeanne Thomassin-Piana3, Julie Gonin4, Jocelyne Chopier5, Martine Antoine4, Isabelle Trop6, Emile Darai7,8, Isabelle Thomassin-Naggara5,8,9.   

Abstract

PURPOSE: To identify pathological features for sample analysis of magnetic resonance imaging-guided vaccum-assisted breast biopsy (MRIgVaBB) to optimize radio pathological correlation and identify discordant benign result.
MATERIAL AND METHODS: Databases of two centres were queried to identify MRIgVaBB performed between January 2009 and February 2013. A cohort of 197 women (mean age: 54.5 years (24-77)) with 208 lesions was identified. We retrospectively analyzed all prebiopsy MRI examinations according to the new BI-RADS lexicon, and all biopsy samples to describe the lesion of interest, its interface with the surrounding breast tissue and other associated features.
RESULTS: The malignancy rate was 26.0 % (54/208) with an underestimation rate of 15.67 % (5/32). A visible interface at pathology between a biopsied lesion and the surrounding breast tissue was more frequently identified in mass enhancement compared to NME or focus (p = 0.0003). Regional NME was correlated with a high degree of fibrosis (p = 0.001) and the presence of PASH (p = 0.0007). Linear or segmental NME was correlated with the presence of periductal mastitis (p = 0.0003).
CONCLUSION: The description of a visible interface between the target lesion and the surrounding tissue is crucial to confirm the correct targeting of an MR mass or a NME. KEY POINTS: • Pathological interface correlated with magnetic resonance mass and focal non-mass enhancement (NME). • Linear or segmental NME correlated with mastitis or ductal carcinoma in situ. • Fibrosis and pseudoangiomatous stromal hyperplasia (PASH) are correlated with regional NME.

Entities:  

Keywords:  Biopsy; Breast; Magnetic Resonance Imaging; Neoplasms; Pathology

Mesh:

Year:  2015        PMID: 26511630     DOI: 10.1007/s00330-015-4071-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

Review 1.  Screening for breast cancer with MRI.

Authors:  Elizabeth A Morris
Journal:  Semin Ultrasound CT MR       Date:  2003-02       Impact factor: 1.875

Review 2.  Image-guided tissue sampling: where radiology meets pathology.

Authors:  Jay Parikh; Ronald Tickman
Journal:  Breast J       Date:  2005 Nov-Dec       Impact factor: 2.431

3.  MR imaging-guided 10-gauge vacuum-assisted breast biopsy: histological characterisation.

Authors:  T Perretta; C A Pistolese; F Bolacchi; E Cossu; V Fiaschetti; G Simonetti
Journal:  Radiol Med       Date:  2008-07-05       Impact factor: 3.469

4.  MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.

Authors:  Susan G Orel; Mark Rosen; Carolyn Mies; Mitchell D Schnall
Journal:  Radiology       Date:  2005-11-22       Impact factor: 11.105

5.  Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization.

Authors:  Isabelle Thomassin-Naggara; Isabelle Trop; Jocelyne Chopier; Julie David; Lucie Lalonde; Emile Darai; Roman Rouzier; Serge Uzan
Journal:  Radiology       Date:  2011-07-19       Impact factor: 11.105

6.  Clinical experience with MRI-guided vacuum-assisted breast biopsy.

Authors:  Constance D Lehman; Elizabeth R Deperi; Sue Peacock; Michelle D McDonough; Wendy B Demartini; Jennifer Shook
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

7.  Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions.

Authors:  Claudia Perlet; Sylvia H Heywang-Kobrunner; Anke Heinig; Harald Sittek; Jan Casselman; Ingvar Anderson; Patrick Taourel
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

8.  Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

Authors:  Francesco Sardanelli; Carla Boetes; Bettina Borisch; Thomas Decker; Massimo Federico; Fiona J Gilbert; Thomas Helbich; Sylvia H Heywang-Köbrunner; Werner A Kaiser; Michael J Kerin; Robert E Mansel; Lorenza Marotti; Laura Martincich; Louis Mauriac; Hanne Meijers-Heijboer; Roberto Orecchia; Pietro Panizza; Antonio Ponti; Arnie D Purushotham; Peter Regitnig; Marco Rosselli Del Turco; Fabienne Thibault; Robin Wilson
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

9.  Short interval follow-up after a benign concordant MR-guided vacuum assisted breast biopsy--is it worthwhile?

Authors:  Sara D Shaylor; Samantha L Heller; Amy N Melsaether; Dipti Gupta; Avani Gupta; James Babb; Linda Moy
Journal:  Eur Radiol       Date:  2014-03-14       Impact factor: 5.315

10.  Outcome of MRI-guided breast biopsy.

Authors:  Boo-Kyung Han; Mitchell D Schnall; Susan G Orel; Mark Rosen
Journal:  AJR Am J Roentgenol       Date:  2008-12       Impact factor: 3.959

View more
  7 in total

Review 1.  MRI-detected breast lesions: clinical implications and evaluation based on MRI/ultrasonography fusion technology.

Authors:  Kazuaki Nakashima; Takayoshi Uematsu; Taiyo L Harada; Kaoru Takahashi; Seiichirou Nishimura; Yukiko Tadokoro; Tomomi Hayashi; Junichiro Watanabe; Takashi Sugino
Journal:  Jpn J Radiol       Date:  2019-09-05       Impact factor: 2.374

2.  Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy.

Authors:  Füsun Taşkın; Aykut Soyder; Ahmet Tanyeri; Veli Süha Öztürk; Alparslan Ünsal
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

3.  Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation.

Authors:  Gustavo Moreno; Mariel Molina; Ruizhe Wu; Julie R Sullivan; Julie M Jorns
Journal:  Breast Cancer Res Treat       Date:  2021-05-27       Impact factor: 4.872

4.  MR imaging-guided vacuum assisted breast biopsy: Radiological-pathological correlation and underestimation rate in pre-surgical assessment.

Authors:  Rosaria Meucci; Adriana Pistolese Chiara; Tommaso Perretta; Gianluca Vanni; Ilaria Portarena; Guglielmo Manenti; Patricia Ryan Colleen; Antonella Castrignanò; Carla Di Stefano; Donatella Ferrari; Feliciana Lamacchia; Marco Pellicciaro; Marco Materazzo; Claudio Buonomo Oreste
Journal:  Eur J Radiol Open       Date:  2020-07-17

5.  Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.

Authors:  Ulrich Bick; Rubina M Trimboli; Alexandra Athanasiou; Corinne Balleyguier; Pascal A T Baltzer; Maria Bernathova; Krisztina Borbély; Boris Brkljacic; Luca A Carbonaro; Paola Clauser; Enrico Cassano; Catherine Colin; Gul Esen; Andrew Evans; Eva M Fallenberg; Michael H Fuchsjaeger; Fiona J Gilbert; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Michel Herranz; Karen Kinkel; Fleur Kilburn-Toppin; Christiane K Kuhl; Mihai Lesaru; Marc B I Lobbes; Ritse M Mann; Laura Martincich; Pietro Panizza; Federica Pediconi; Ruud M Pijnappel; Katja Pinker; Simone Schiaffino; Tamar Sella; Isabelle Thomassin-Naggara; Anne Tardivon; Chantal Van Ongeval; Matthew G Wallis; Sophia Zackrisson; Gabor Forrai; Julia Camps Herrero; Francesco Sardanelli
Journal:  Insights Imaging       Date:  2020-02-05

6.  Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women.

Authors:  Yu Tan; Hui Mai; Zhiqing Huang; Li Zhang; Chengwei Li; Songxin Wu; Huang Huang; Wen Tang; Yongxi Liu; Kuiming Jiang
Journal:  BMC Med Imaging       Date:  2021-03-12       Impact factor: 1.930

7.  Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses.

Authors:  Yan Li; Zhenlu L Yang; Wenzhi Z Lv; Yanjin J Qin; Caili L Tang; Xu Yan; Yihao H Guo; Liming M Xia; Tao Ai
Journal:  Front Oncol       Date:  2021-09-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.